Evidence map›Paper›PMID 42774744›Full record

ArticleOpen forum infectious diseases2026

Satisfaction and Treatment Burden Among Early Adopters of Long-Acting Injectable Cabotegravir-Rilpivirine With and Without Viremia in Three US Ryan White Clinics.

Katerina A Christopoulos, Alex Beckert, Caleb McCracken, Kaylin Dance, Sophie Plotkin, Lauren F Collins, Moira C McNulty, Matthew D Hickey, Mallory O Johnson, Aaloke Mody and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Katerina A ChristopoulosDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-8598-2191
Alex BeckertDepartment of Medicine, Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0009-0002-6074-2199
Caleb McCrackenDepartment of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.
Kaylin DanceDepartment of Medicine, Emory University, Ponce De Leon Center, Grady Health System, Atlanta, Georgia, USA.
Sophie PlotkinDepartment of Medicine, University of Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0009-0000-3707-1679
Lauren F CollinsDepartment of Medicine, Emory University, Ponce De Leon Center, Grady Health System, Atlanta, Georgia, USA.
Moira C McNultyDepartment of Medicine, University of Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-9651-254X
Matthew D HickeyDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Mallory O JohnsonDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-0480-2804
Aaloke ModyDepartment of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0003-3787-365X
Xavier A ErgueraDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-7632-0321
Kimberly A KoesterDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Geoffroy LiegeonDepartment of Medicine, University of Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0003-1267-4347
Jorge SalazarDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-7888-4198
Jose GutierrezDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-3231-0794
Janet GrochowskiDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Samantha E DilworthDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-5451-5486
Torsten B NeilandsDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0001-7936-9123
Elizabeth T MontgomeryDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Jonathan A ColasantiDepartment of Medicine, Emory University, Ponce De Leon Center, Grady Health System, Atlanta, Georgia, USA.

Funding

Understanding Patient, Provider, and Systems Stakeholder Attitudes and Preferences to Optimize Implementation of Long-Acting Injectable Antiretrovirals and Maximize Clinical and Public Health ImpactR01MH123396 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTOPOULOS, KATERINA A, HICKEY, MATTHEW · 2020 to 2023
$3.2M
NIMH NIH HHS R01 MH123396
6 · The paper itself

Abstract

Among underserved people with HIV with a median of one year of long-acting cabotegravir-rilpivirine use, including those starting with viremia due to adherence challenges, we found higher satisfaction and lower treatment burden compared to daily oral ART, although nearly half preferred another dosing modality and/or a longer dosing interval.

Indexed as

adherence challengescabotegravir-rilpivirinelong-acting antiretroviral therapypatient-reported outcomessatisfaction

Identifiers

PMID42774744
PMCPMC13595248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.